---
title: Use of Autologous Bone Graft with Bioactive Glass as a Bone Substitute in the
  Treatment of Large-Sized Bone Defects of the Femur and Tibia
date: '2023-12-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38138871/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231223170641&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Bioactive glass (BaG) in combination with autologous bone
  (RIA) appears to be a suitable filler material for treating extensive non-unions
  of the femur and tibia. This approach seems to show non-inferiority to treatment
  with Tricalcium Phosphate (TCP). To ensure the success of this treatment, it is
  crucial to validate the procedure through a randomized controlled trial (RCT) with
  a control group using TCP, which would provide higher statistical power and more
  reliable ...'
disable_comments: true
---
CONCLUSIONS: Bioactive glass (BaG) in combination with autologous bone (RIA) appears to be a suitable filler material for treating extensive non-unions of the femur and tibia. This approach seems to show non-inferiority to treatment with Tricalcium Phosphate (TCP). To ensure the success of this treatment, it is crucial to validate the procedure through a randomized controlled trial (RCT) with a control group using TCP, which would provide higher statistical power and more reliable ...